3. Schmidt A, Hescheler L Offermanns Set al. (1991) Involvement of pertussis toxin-sensitive G-proteins in the hormonal inhibition of dihydropyridine-sensitive Ca2 + currents in an insulin-secreting cell line (RINm5F Large-scale study of an A-to-G transition at position 3243 of the mitochondrial gene and IDDM in Japanese patients
Dear Sir, The most frequent gene mutation in Japanese patients with non-insulin-dependent diabetes mellitus (NIDDM) was recently reported to be an A-to-G transition at position 3243 of the mitochondrial gene (3243 base pair (bp) mutation) (-1%). Otabe et al. [1] and Odawara et al. [2] identified it in 5 of 550 NIDDM patients and 3 of 300 NIDDM patients who also had impaired glucose tolerance (IGT). It seems that approximately 1% of the cases of NIDDM in Japanese patients may be strongly associated with and/or caused by the 3243 bp mitochondrial gene mutation. On the other hand, Oka et al. [3] reported that approximately 10 % of patients with slowly progressive insulin-dependent diabetes (IDDM), which was characterized by a clinical course including a period of several years without insulin treatment, decreasing C-peptide response and tong-term islet cell antibody positivity, had the 3243 bp mitochondrial mutation. Indeed, it is sometimes difficult to determine the type of diabetes in lean young Japanese patients because they sometimes exhibit a low C-peptide response which requires insulin treatment without abrupt onset of diabetes, and proneness to ketosis. We recently reported that 6 of 102 (5.9 %) lean female patients who developed NIDDM at a young age (25.0_+ 6.3 years) had the 3243 bp mitochondrial mutation; these six patients were diagnosed as having insulin-requiring NIDDM because they did not exhibit abrupt onset of diabetes or ketoCorresponding author." Dr. Y. Uchigata, Diabetes Center, Tokyo Women's Medical College, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162, Japan sis/ketoacidosis. Moreover, we reported that none of 64 IDDM patients had the 3243 bp mutation [4] . Although Odawara et al. [2] reported a similar finding (among 94 IDDM patients no patients with the 3243 bp mutation were found), it is difficult to support statistically the lack of an association between the 3243 bp mutation and IDDM development based only on such small-scale studies of IDDM patients. Therefore, we conducted a large-scale study to investigate whether patients with well-defined IDDM possess the 3243 bp mutation which might produce autoimmunity leading to IDDM.
The study population (n = 568, male/female = 203/365 [5] ) comprised 489 IDDM patients who were residents of the Tokyo area treated at the Diabetes Center, Tokyo Women's Medical College, 29 IDDM patients treated at several hospitals who were residents of the "Hokkaido" area and 50 IDDM patients treated at the Department of Geriatric Medicine, Osaka University Medical School who were residents of the Osaka area. The diagnosis of IDDM was based on the criteria of the National Diabetes Data Group with a further requirement of low C-peptide values. The 3243 bp mutation in mitochondrial DNA extracted fi'om peripheral blood cells was detected using the polymerase chain reaction (PCR) method with a probe specific to this mutation [6] ; the PCR products were digested with the restriction endonuclease Apa I followed by silver staining [4] . Using this method we detected 0.6 % heteroplasmy of the mutation [4] . Table I shows the baseline characteristics of the IDDM patients divided into four groups. Some of them had parents with NIDDM or siblings with IDDM. The frequency of coma or ketoacidosis at the time of diagnosis showed significant differences in age at onset (p < 0.002). The greater the age at onset, the less frequent was coma or ketoacidosis at the time of diagnosis. The 3243 bp mutation was not detected in any of the IDDM patients (p = 0.0285 vs 5 of 550 NIDDM patients [1] and p = 0.0418 vs 3 of 300 NIDDM + IGT patients [2] by Fisher's exact probability analysis). The result of this study demon- 
